Notice of Effectiveness
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 11, 2022 4:00 P.M. |
| Form: | S-3 | |||||
|
Attachments
Disclaimer
Accelerate Diagnostics Inc. published this content on 11 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 February 2022 14:32:20 UTC.